Literature DB >> 25731642

Complications of sclerotherapy for 75 head and neck venous malformations.

Eeva Castrén1, Johanna Aronniemi2, Tuomas Klockars3, Johanna Pekkola2, Kimmo Lappalainen2, Pia Vuola4, Päivi Salminen5, Anne Pitkäranta3.   

Abstract

Sclerotherapy is one treatment option for head and neck venous malformations (VMs). Evaluation of complication risks is, however, essential to improve its safety. We aimed to systematically report sclerotherapy complications by means of the Clavien-Dindo classification and to distinguish factors predisposing to complications. We identified our institution's head and neck VM patients who received sclerotherapy between 1 January 2007 and 31 August 2013, analyzed patient reports retrospectively, and applied to them the Clavien-Dindo classification. Our 75 VM patients underwent a total of 150 sclerotherapy sessions. The most common sclerosants were 3 % sodium tetradecyl sulfate and polidocanol. Complications occurred in 13 patients (17.3 %) and in 15 sessions (10.0 %); 3 complications required extensive postprocedural treatment and caused permanent morbidity, whereas 12 received conservative treatment. Patients with sclerotherapy complications underwent more treatments (p = 0.009) and more often needed further surgery (p = 0.007). We thus consider sclerotherapy a relatively safe treatment modality for head and neck VMs. To avoid complications, evaluation of VM characteristics and optimal treatment technique in a multidisciplinary team is vital.

Entities:  

Keywords:  Clavien-Dindo classification; Safety; Treatment; Vascular anomaly

Mesh:

Substances:

Year:  2015        PMID: 25731642     DOI: 10.1007/s00405-015-3577-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  48 in total

Review 1.  Current classification and terminology of pediatric vascular anomalies.

Authors:  Ramya Kollipara; Laura Dinneen; Kenny E Rentas; Megan R Saettele; Suchit A Patel; Douglas C Rivard; Lisa H Lowe
Journal:  AJR Am J Roentgenol       Date:  2013-11       Impact factor: 3.959

2.  Percutaneous ethanol sclerotherapy of venous malformations of the tongue.

Authors:  Philip L Johnson; Donald A Eckard; Marci A Brecheisen; Douglas A Girod; Terrence T Tsue
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

3.  Nd: YAG laser therapy of voluminous hemangiomas and vascular malformations.

Authors:  J A Werner; B M Lippert; P Hoffmann; H Rudert
Journal:  Adv Otorhinolaryngol       Date:  1995

4.  Soft-tissue venous malformations in adult patients: imaging and therapeutic issues.

Authors:  J Dubois; G Soulez; V L Oliva; M J Berthiaume; C Lapierre; E Therasse
Journal:  Radiographics       Date:  2001 Nov-Dec       Impact factor: 5.333

5.  [Pulmonary emboli in sclerotherapy for peripheral vascular malformations under general anesthesia; a report of two cases].

Authors:  Kaori Tachibana; Shigeaki Kobayashi; Taku Kojima; Shigeo Kaseno; Osamu Kemmotsu
Journal:  Masui       Date:  2004-06

6.  Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck.

Authors:  Matthew David Alexander; Ryan A McTaggart; Omar A Choudhri; Mary L Marcellus; Huy M Do
Journal:  J Neurointerv Surg       Date:  2013-11-14       Impact factor: 5.836

7.  Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck.

Authors:  Nobuyuki Kaji; Masakazu Kurita; Mine Ozaki; Akihiko Takushima; Kiyonori Harii; Mitsunaga Narushima; Shinichi Wakita
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  2009

8.  Venous malformations of skeletal muscle.

Authors:  Katherine D Hein; John B Mulliken; Harry P W Kozakewich; Joseph Upton; Patricia E Burrows
Journal:  Plast Reconstr Surg       Date:  2002-12       Impact factor: 4.730

9.  Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results.

Authors:  In Ho Lee; Keon Ha Kim; Pyoung Jeon; Hong Sik Byun; Hyung-Jin Kim; Sung Tae Kim; Young Wook Kim; Dong-Ik Kim; Joon Young Choi
Journal:  Korean J Radiol       Date:  2009-04-22       Impact factor: 3.500

Review 10.  Unexpected development of tongue squamous cell carcinoma after sclerotherapy for the venous malformation: a unique case report and literature review.

Authors:  Gang Chen; Xu Cai; Jian-Gang Ren; Jun Jia; Yi-Fang Zhao
Journal:  Diagn Pathol       Date:  2013-11-04       Impact factor: 2.644

View more
  6 in total

1.  Venous Malformation of the Parotid Gland.

Authors:  Shifa Zareena; K B Dinesh; Bharath Narayanasami; G Marunraj; Arcot Rekha
Journal:  Int J Angiol       Date:  2019-07-15

2.  Peri-procedural Anticoagulation in Patients with Head and Neck Versus Extremity Venous Malformations.

Authors:  Harish Dharmarajan; Jennifer L McCoy; Noel Jabbour; Andrew McCormick; Frederico Xavier; Debra Correa; Reema Padia
Journal:  Laryngoscope       Date:  2020-10-10       Impact factor: 3.325

3.  A Prospective Randomized Controlled Trial Using Propofol or Dexmedetomidine for Conscious Sedation in Pediatric Patients Undergoing Sclerotherapy.

Authors:  Rajeev Chauhan; Ankur Luthra; Sameer Sethi; Nidhi Panda; Shyam Charan Meena; Vikas Bhatia; Summit D Bloria
Journal:  J Pediatr Neurosci       Date:  2021-01-19

4.  Intramuscular Hemangioma of Masseter Muscle: Case Report of Rare Clinical Entity.

Authors:  Ramanpal Singh Makkad; Gunjan Agarwal; Santosh Gupta; Ravleen Nagi; Akshay Ragit; Farhin Jamal
Journal:  Ann Maxillofac Surg       Date:  2021-07-24

Review 5.  Orbital infarction syndrome after multiple percutaneous sclerotherapy sessions for facial low-flow vascular malformation: A case report and literature review.

Authors:  Weng Sut Sio; Shwu-Huey Lee; I-Chia Liang
Journal:  Indian J Ophthalmol       Date:  2016-08       Impact factor: 1.848

6.  Role of Interventional Radiology in the Management of Peripheral Vascular Malformations: A Tertiary Care Center Experience.

Authors:  Misbah Tahir; Muhammad Anees Mumtaz; Anum Sultan; Jawaid Iqbal; Raza Sayani
Journal:  Cureus       Date:  2018-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.